{ "company_number": "09027019", "name": "Nadjo Biomedicals Limited", "url": "/company/09027019", "status": "active", "is_active": true, "company_type": "ltd", "incorporated_on": "2014-05-07", "dissolved_on": null, "sic_codes": [ "86101" ], "registered_address": { "id": 1652493, "url": "/address/1652493", "line1": "40 PAMPLINS", "line2": "", "post_town": "BASILDON", "county": "", "country": "ENGLAND", "postcode": "SS15 5BL" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09027019", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-02-28", "last_made_up": "2025-05-31", "category": "MICRO ENTITY", "filings": [ { "url": "/company/09027019/accounts/2026-05-31", "made_up_date": "2026-05-31", "period_start": "2026-05-31", "period_end": "2026-05-31", "entity_name": "Nadjo Biomedicals Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "4433.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-2787.00", "total_assets_less_current_liabilities": "1646.00", "net_assets_liabilities": "1646.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1646.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Bulk_Data-2026-08-06.zip" }, { "url": "/company/09027019/accounts/2025-05-31", "made_up_date": "2025-05-31", "period_start": "2025-05-31", "period_end": "2025-05-31", "entity_name": "Nadjo Biomedicals Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "6650.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "3816.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1035.00", "total_assets_less_current_liabilities": "7685.00", "net_assets_liabilities": "7685.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "7685.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2025.zip" }, { "url": "/company/09027019/accounts/2024-05-31", "made_up_date": "2024-05-31", "period_start": "2024-05-31", "period_end": "2024-05-31", "entity_name": "Nadjo Biomedicals Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "8867.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "3733.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "952.00", "total_assets_less_current_liabilities": "9819.00", "net_assets_liabilities": "9819.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "9819.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2024.zip" }, { "url": "/company/09027019/accounts/2023-05-31", "made_up_date": "2023-05-31", "period_start": "2023-05-31", "period_end": "2023-05-31", "entity_name": "Nadjo Biomedicals Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "11156.00", "debtors": null, "cash_bank_in_hand": "585.00", "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-7866.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "3290.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "150.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2023.zip" }, { "url": "/company/09027019/accounts/2022-05-31", "made_up_date": "2022-05-31", "period_start": "2022-05-31", "period_end": "2022-05-31", "entity_name": "Nadjo Biomedicals Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "845.00", "debtors": null, "cash_bank_in_hand": "-630.00", "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-774.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "71.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "150.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2023.zip" }, { "url": "/company/09027019/accounts/2021-05-31", "made_up_date": "2021-05-31", "period_start": "2021-05-31", "period_end": "2021-05-31", "entity_name": "Nadjo Biomedicals Limited", "dormant": false, "average_employees": "0.00", "tangible_fixed_assets": "845.00", "debtors": null, "cash_bank_in_hand": "-630.00", "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-774.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "71.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "150.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2022.zip" }, { "url": "/company/09027019/accounts/2020-05-31", "made_up_date": "2020-05-31", "period_start": "2020-05-31", "period_end": "2020-05-31", "entity_name": "Nadjo Biomedicals Limited", "dormant": false, "average_employees": "0.00", "tangible_fixed_assets": "845.00", "debtors": null, "cash_bank_in_hand": "-630.00", "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-774.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "71.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "150.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2021.zip" }, { "url": "/company/09027019/accounts/2019-05-31", "made_up_date": "2019-05-31", "period_start": "2019-05-31", "period_end": "2019-05-31", "entity_name": "Nadjo Biomedicals Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "845.00", "debtors": null, "cash_bank_in_hand": "-630.00", "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-774.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "71.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "150.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2019.zip" }, { "url": "/company/09027019/accounts/2018-05-31", "made_up_date": "2018-05-31", "period_start": "2018-05-31", "period_end": "2018-05-31", "entity_name": "Nadjo Biomedicals Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "845.00", "debtors": null, "cash_bank_in_hand": "-630.00", "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-774.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "71.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "150.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2019.zip" }, { "url": "/company/09027019/accounts/2017-05-31", "made_up_date": "2017-05-31", "period_start": "2017-05-31", "period_end": "2017-05-31", "entity_name": "Nadjo Biomedicals Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "1690.00", "debtors": null, "cash_bank_in_hand": "-480.00", "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-1381.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "309.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "150.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2018.zip" }, { "url": "/company/09027019/accounts/2016-05-31", "made_up_date": "2016-05-31", "period_start": "2016-05-31", "period_end": "2016-05-31", "entity_name": "Nadjo Biomedicals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "2535.00", "debtors": null, "cash_bank_in_hand": "1923.00", "current_assets": null, "creditors_due_within_one_year": "3164.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-1241.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "1294.00", "called_up_share_capital": "150.00", "profit_loss_account_reserve": "1144.00", "shareholder_funds": "1294.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2017.zip" }, { "url": "/company/09027019/accounts/2015-05-31", "made_up_date": "2015-05-31", "period_start": "2015-05-31", "period_end": "2015-05-31", "entity_name": "Nadjo Biomedicals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "3380.00", "debtors": null, "cash_bank_in_hand": "1778.00", "current_assets": "1778.00", "creditors_due_within_one_year": "4677.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-2899.00", "total_assets_less_current_liabilities": "481.00", "net_assets_liabilities": "481.00", "called_up_share_capital": "150.00", "profit_loss_account_reserve": "331.00", "shareholder_funds": "481.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2015.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/09027019/filing-history" }, "confirmation_statement": { "next_due": "2027-04-19", "last_made_up": "2026-04-05" }, "officers": [], "psc": [ { "name": "Mrs Adjoa Asiedua Sakyi-Gyinae", "kind": "individual-person-with-significant-control", "person_url": "/person/88095", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-50-to-75-percent" ], "notified_on": "2017-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "stream", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-05T11:25:05+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }